[ad_1] Daiichi Sankyo shares 4568, +14.42% rose sharply after the Japanese drugmaker announced a multibillion…
Tag:
Cancer Drugs
-
-
STOCK MARKET
Johnson & Johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech business
by userby user[ad_1] Johnson & Johnson on Tuesday posted better-than-expected third-quarter earnings and raised its profit guidance…
-
STOCK MARKET
Tempest Therapeutics’ stock jumps 1,900% as liver-cancer treatment shows promise
by userby user[ad_1] Shares of Tempest Therapeutics Inc. TPST soared more than 1,900% on Wednesday after the…
-
STOCK MARKET
Shares in weapons makers Lockheed Martin, RTX surge following surprise attack on Israel and other stocks on the move
by userby user[ad_1] Here are some of the day’s biggest movers: Stock gainers: Defense contractors including RTX…
-
STOCK MARKET
Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion
by userby user[ad_1] Bristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a…
-
STOCK MARKET
Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel votes against it
by userby user[ad_1] Amgen Inc. said it would continue to work closely with the Food and Drug…
-
STOCK MARKET
Medicare drug price negotiations move forward with all drugmakers participating, White House says
by userby user[ad_1] All of the primary manufacturers of the 10 drugs selected in August for Medicare…
-
[ad_1] Here are some of the biggest movers in Tuesday’s premarket action: Stock gainers: Shares…
-
STOCK MARKET
Merck and Eisai say two lung-cancer trials failed to meet their main goals
by userby user[ad_1] Merck and Japanese partner Eisai said Friday that two late-stage trials of a treatment…
-
STOCK MARKET
As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit — even if their drugs aren’t on the list
by userby user[ad_1] Medicare in the coming days will announce the first 10 drugs selected for price…